Although a greater proportion of patients with severe infections were on glucocorticoids and biologics, the difference between users and non-users of these medications did not reach statistical significance.
← all excerpts
Severe infections remain common in a real-world rheumatoid arthritis cohort: A simple clinical model to predict infection risk.
1
—
—